The before‐mentioned findings trigger a possible mechanism that GRHL2 might be involved in NAFLD via miR‐200‐targeted SIRT1 and MAPK signalling pathway. This evidence concerns the gene GRHL2 and metabolic dysfunction-associated steatotic liver disease.